HomeWebcastPatent Term Adjustment Post-Supernus: Best Practices for Applicants
Online CLE Post-Supernus CLE

Patent Term Adjustment Post-Supernus: Best Practices for Applicants

Live Webcast Date: Monday, December 16, 2019 from 3:00 pm to 5:00 pm (ET)
Intellectual Property Law (CLE)Live Webcast
Registration & Pricing Options
Add to Calendar 12/16/2019 3:00 pm 12/16/2019 5:00 pm America/New_York The Knowledge Group Webinar: Patent Term Adjustment Post-Supernus: Best Practices for Applicants If you haven’t registered for this event please click here:https://www.theknowledgegroup.org/checkout/?add-to-cart=136282\r\n In view of the Federal Circuit’s January 2019 ruling in Supernus Pharmaceuticals, Inc. v. Iancu, the U.S. Patent and Trademark Office (USPTO) released new guidelines which patent owners can follow when challenging patent term adjustment (PTA) awards. In Supernus, the Federal Circuit reversed and remanded the district court’s ruling which favored the USPTO’s 646-day-period PTA deduction in light of a Supplemental Information Disclosure Statement (IDS) filing. The court held that the district court erred when it granted summary judgment for USPTO by applying Gilead. \n \nThis case emphasizes the need for patent applicants to verify the accuracy of USPTO’s PTA determinations. They should have their own PTA calculation that is compliant with USPTO rules and file a request for reconsideration should they find any error with USPTO’s calculation. \n \nIn this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the Supernus case as well as the USPTO’s new PTA procedures. Speakers will also offer the best practices which patent applicants should take considering the Supernus ruling. \n \nKey topics include: \n \n \n The Supernus Pharmaceuticals, Inc. v. Iancu – An Overview \n The USPTO’s New PTA Guidelines \n Applicant Delay Issues \n Best Practices for Applicants \n Outlook Post-Supernus \n https://www.theknowledgegroup.org/webcasts/patent-term-adjustment-post-supernus/

Online CLE Post-Supernus

Join us for this Knowledge Group Online CLE Post-Supernus Webinar. In view of the Federal Circuit’s January 2019 ruling in Supernus Pharmaceuticals, Inc. v. Iancu, the U.S. Patent and Trademark Office (USPTO) released new guidelines which patent owners can follow when challenging patent term adjustment (PTA) awards. In Supernus, the Federal Circuit reversed and remanded the district court’s ruling which favored the USPTO’s 646-day-period PTA deduction in light of a Supplemental Information Disclosure Statement (IDS) filing. The court held that the district court erred when it granted summary judgment for USPTO by applying Gilead.

This case emphasizes the need for patent applicants to verify the accuracy of USPTO’s PTA determinations. They should have their own PTA calculation that is compliant with USPTO rules and file a request for reconsideration should they find any error with USPTO’s calculation.

In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the Supernus case as well as the USPTO’s new PTA procedures. Speakers will also offer the best practices which patent applicants should take considering the Supernus ruling.

Key topics include:

  • The Supernus Pharmaceuticals, Inc. v. Iancu – An Overview
  • The USPTO’s New PTA Guidelines
  • Applicant Delay Issues
  • Best Practices for Applicants
  • Outlook Post-Supernus

Agenda

Daniel A. Rubé, Ph.D., Attorney
Troutman Sanders LLP

Who Should Attend

  • In-house Counsel
  • Patent Agents
  • Patent Applicants
  • Top Level Management
  • Patent Lawyers and Consultants

Online CLE Post-Supernus

Daniel A. Rubé, Ph.D., Attorney
Troutman Sanders LLP

Online CLE Post-Supernus

Online CLE Post-Supernus

Daniel A. Rubé, Ph.D.AttorneyTroutman Sanders LLP

Dr. Daniel Rubé has practiced intellectual property law for over ten years, focusing primarily on patent prosecution and due diligence.  He studied chemistry at the State University of New York at Buffalo, and received a Ph.D. in biological chemistry at UCLA.  He has a law degree from Stanford.  His research experience is in cell biology, molecular biology, genetics and biochemistry.  Daniel finds science fun and interesting, and likes challenges with cutting edge technology.  His patent experience includes these areas as well as immunology, DNA sequencing, pharmaceutical and cosmetic formulations, polymers, and materials science.  He serves large companies, startups, universities, research institutes and solo inventors. 


Click Here to Read Additional Material

Online CLE Post-Supernus

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   Live Webcast

Prerequisite:
   General knowledge of patent laws

Course Code:
   148355

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Troutman Sanders has four core practices—Transactional, Business Litigation, Specialized Litigation, and Regulatory & Finance, under which it boasts 16 sections, including intellectual property law.  For Troutman Sanders, practicing law is about commitment, with a “higher commitment to client care” being one of the most important values that differentiates Troutman Sanders from other law firms.  In recognition of Troutman’s strong client service culture, the firm has been on the BTI Client Service A-Team for 13 consecutive years.  Troutman develops and implements global protection and commercialization strategies for clients with intellectual property assets in virtually all industry areas.  Many of Troutman’s attorneys and professionals have Ph.D.s and other advanced technical degrees in a wide variety of disciplines, and enjoyed successful careers as inventors, researchers, engineers, physicians and scientists prior to joining the firm.

Website: https://www.troutman.com/

Dr. Daniel Rubé has practiced intellectual property law for over ten years, focusing primarily on patent prosecution and due diligence.  He studied chemistry at the State University of New York at Buffalo, and received a Ph.D. in biological chemistry at UCLA.  He has a law degree from Stanford.  His research experience is in cell biology, molecular biology, genetics and biochemistry.  Daniel finds science fun and interesting, and likes challenges with cutting edge technology.  His patent experience includes these areas as well as immunology, DNA sequencing, pharmaceutical and cosmetic formulations, polymers, and materials science.  He serves large companies, startups, universities, research institutes and solo inventors. 

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199